ea0090p454 | Reproductive and Developmental Endocrinology | ECE2023
Lakshitha de Silva Nipun
, Dissanayake Harsha
, Suarez Camila
, Wickramarachchi R. E.
, Ramasamy Ranjith
, Dhillo Waljit
, Minhas Suks
, Corona Giovanni
, Jayasena Channa
Introduction: Selective oestrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) potentially increase endogenous gonadotrophin and testosterone secretion in men. They are used off-label in men with hypogonadism and/or infertility. There is a lack of guidance on using these agents in men with secondary hypogonadism, though these agents are widely used in these people as a cheaper alternative to gonadotrophins. Methods: Systematic search was co...